Category: Medical device company
Industry: Drug Manufacturers - Major Quick infos Headquarters: New Brunswick, New Jersey, United States Trade prices Volume: Market Cap: 434.04B Prev closed: Open: 166.19 High: 167.99 Low: 164.47 52 week low: 151.47 52 week high: 179.92 Dividends: Next ER: January 25, 2022 Before Market Opens
About the Company Johnson & Johnson is an American multinational medical devices, pharmaceutical and consumer packaged goods manufacturing company founded in 1886.
Earnings History Date EPS / Forecast Revenue / Forecast January 25, 2022 October 19, 2021 2.6 / 2.3623.34B / 23.66BJuly 21, 2021 2.48 / 2.2923.31B / 22.49BBeat! April 20, 2021 2.59 / 2.3422.32B / 21.98BBeat! January 26, 2021 1.86 / 1.8222.48B / 21.66BBeat! view more
Historical Data Date Price Open High Low Vol Change ER Jan 21, 2022 164.87 166.19 167.99
164.47
10.50M -0.23% Jan 20, 2022 165.25 167.29 167.86
164.93
5.81M -0.8% Jan 19, 2022 166.58 167.20 168.72
166.32
5.92M -0.31% Jan 18, 2022 167.10 167.10 167.71
166.01
7.33M -0.44% Jan 14, 2022 167.84 168.63 168.65
167.15
5.85M -0.55% Jan 13, 2022 168.76 169.00 170.42
168.46
5.86M -0.61% Jan 12, 2022 169.79 169.61 170.08
168.34
8.12M -0.85% Jan 11, 2022 171.25 172.99 173.39
170.11
8.13M -1.06% Jan 10, 2022 173.09 173.69 173.69
172.15
7.68M -0.49% Jan 7, 2022 173.95 171.46 174.30
171.13
6.99M 1.35% view more
NYSE - New York Stock Exchange
More profiles and info about the company ISIN: US4781601046 CUSIP: 478160104 Founded:January 1886 Employees:126,400 News
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2020 johnsonandjohnson.gcs-web.com Jul 21, 2020 1:40 am Johnson & Johnson to Participate in Citi ‘Of Hearts and Minds’ Conference Call Series johnsonandjohnson.gcs-web.com Jul 17, 2020 11:30 pm Interim Six-Month Data of RPGR Gene Therapy Shows Significant Vision Improvement in Patients Living with X-Linked Retinitis Pigmentosa johnsonandjohnson.gcs-web.com Jul 17, 2020 9:00 pm U.S. FDA Approves New MENTOR® MemoryGel BOOST™ Breast Implant johnsonandjohnson.gcs-web.com Jan 14, 2022 1:00 am Johnson & Johnson Medical Devices Companies Announces Strategic Partnership with Microsoft to Further Enable its Digital Surgery Solutions johnsonandjohnson.gcs-web.com Jan 11, 2022 4:00 am Johnson & Johnson Announces Quarterly Dividend for First Quarter 2022 johnsonandjohnson.gcs-web.com Jan 4, 2022 9:00 pm Johnson & Johnson COVID-19 Vaccine Demonstrates 85 Percent Effectiveness against Hospitalization in South Africa when Omicron was Dominant johnsonandjohnson.gcs-web.com Dec 30, 2021 11:00 pm Janssen Submits Biologics License Application to U.S. FDA Seeking Approval of Teclistamab for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma johnsonandjohnson.gcs-web.com Dec 29, 2021 11:00 pm FDA Approves Two New Indications for XARELTO® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients johnsonandjohnson.gcs-web.com Dec 21, 2021 1:00 am Johnson & Johnson Announces Positive CHMP Opinion for a Booster Shot of its COVID-19 Vaccine johnsonandjohnson.gcs-web.com Dec 15, 2021 9:00 pm Janssen Presents Updated Results Evaluating First-in-Class Talquetamab (GPRC5DxCD3 Bispecific Antibody) in Heavily Pretreated Patients with Multiple Myeloma johnsonandjohnson.gcs-web.com Dec 12, 2021 1:00 am New Clinical and Real-World Data Support Use of DARZALEX® (daratumumab) in Patients with Newly Diagnosed Multiple Myeloma johnsonandjohnson.gcs-web.com Dec 12, 2021 1:00 am Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results johnsonandjohnson.gcs-web.com Dec 11, 2021 1:00 am World Health Organization Strategic Advisory Group of Experts (SAGE) Interim Recommendation Supports Use of Johnson & Johnson COVID-19 Vaccine as a Booster johnsonandjohnson.gcs-web.com Dec 10, 2021 1:00 am Johnson & Johnson Appoints Senior Leaders to Executive Committee johnsonandjohnson.gcs-web.com Dec 9, 2021 9:30 pm Johnson & Johnson to Participate in the 40th Annual J.P. Morgan Healthcare Conference johnsonandjohnson.gcs-web.com Dec 8, 2021 1:00 am Johnson & Johnson COVID-19 Booster, Administered Six Months After Two-Dose Regimen of BNT162b2, Shows Substantial Increase in Antibody and T-cell Responses johnsonandjohnson.gcs-web.com Dec 5, 2021 9:00 pm U.S. FDA Approves DARZALEX FASPRO® (daratumumab and hyaluronidasefihj) in Combination with Carfilzomib and Dexamethasone for Patients with Multiple Myeloma After First or Subsequent Relapse johnsonandjohnson.gcs-web.com Dec 2, 2021 1:00 am Johnson & Johnson COVID-19 Vaccine Fully Approved by Health Canada to Prevent COVID-19 in Individuals 18 years and Older johnsonandjohnson.gcs-web.com Nov 24, 2021 10:00 pm European Commission Approves BYANNLI® (6-monthly Paliperidone Palmitate; PP6M) for the Maintenance Treatment of Schizophrenia in Adults johnsonandjohnson.gcs-web.com Nov 23, 2021 10:00 pm JNJ Dividends Ex-Dividend Amount Announced Date Record Date Payment Date Feb 18, 2022 1.06 Mar 8, 2022 Nov 22, 2021 1.06 Dec 7, 2021 Aug 23, 2021 1.06 Sep 7, 2021 May 24, 2021 1.06 Jun 8, 2021 Feb 22, 2021 1.01 Mar 9, 2021 view more
Key Persons Talk about Johnson below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Homepage: jnj.com Consensus
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon While many books explain the how of bitcoin, The Internet of Money delves into the why of bitcoin. Acclaimed information-security expert and author of Mastering Bitcoin, Andreas M. Antonopoulos examines and contextualizes the significance of bitcoin through a series of essays spanning the exhilarating maturation of this technology.
